AnaptysBio, Inc.
ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)

Last updated:

Abstract:

The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to interleukin-33 (IL-33). The invention provides an IL-33-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. The invention also provides related vectors, compositions, and methods of using the IL-33-binding agent to treat a disorder in a mammal that is responsive to IL-33 inhibition.

Status:
Application
Type:

Utility

Filling date:

15 Oct 2020

Issue date:

11 Feb 2021